China Traditional Chinese Medicine Holdings
Launch date
Employees
Market cap
CAD3.6b
Enterprise valuation
CAD3.8b (Public information from Sep 2024)
Share price
HKD4.35 0570.HK
Wan Chai District Hong Kong Island (HQ)
Financials
Estimates*
| CNY | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 14.8b | 19.1b | 14.3b | 18.1b | 20.0b | 22.5b | 26.1b |
| % growth | 3 % | 29 % | (25 %) | 27 % | 10 % | 12 % | 16 % |
| EBITDA | 3.2b | 3.6b | 2.3b | 2.6b | 2.8b | 3.2b | 3.6b |
| % EBITDA margin | 22 % | 19 % | 16 % | 14 % | 14 % | 14 % | 14 % |
| Profit | 1.7b | 1.9b | 764m | 1.3b | 1.4b | 1.5b | 1.8b |
| % profit margin | 11 % | 10 % | 5 % | 7 % | 7 % | 7 % | 7 % |
| EV / revenue | 1.0x | 1.1x | 1.0x | 1.1x | 0.7x | 0.8x | 0.4x |
| EV / EBITDA | 4.6x | 5.6x | 6.3x | 7.5x | 4.7x | 5.3x | 3.0x |
| R&D budget | 550m | 694m | 612m | 686m | - | - | - |
| R&D % of revenue | 4 % | 4 % | 4 % | 4 % | - | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| Total Funding | - | ||
